RE:RE:FTC blockage of Amgen's US$28 BLN takeover of HorizonHello Noteable,
In my view, the aquisition of ONCY by any company should not really pose a threat to competition in specific markets (which would attract anti-trust attention). That is because we have no sales at present, and no other company has the same kind of viral treatment. If we were to be bought by some company that already owned all or most of the other oncolytic viruses, that might be percieved as a anti-competitive move. But aside from that, it is hard to imagine a competition problem IMHO.